Website profile

Yahoo! Finance Uk

At Yahoo Finance, you can receive free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

  • 919articles · 30d
  • 3+ hour agolatest article
  • Aug 14, 2026earliest in window
  • 87%with images
  • 300avg words
articles per day
Categories
  • Economy, Business & Finance 768
  • Finance & Business 684
  • News 387
  • Finance 208
  • Business & Industrial 85
  • Transportation 32
  • Industrial 31
  • Travel & Transportation 27

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Yahoo Finance
uk.finance.yahoo.com > news > roche-collaborator-medilink-announces-phase-000000556.html

Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer

22+ hour, 16+ min ago   (328+ words) Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achieving an objective response rate of 59.1% vs 9.7%1 The novel B7-H3-targeted antibody-drug conjugate…...

Yahoo Finance
uk.finance.yahoo.com > news > astrazeneca-ditches-lung-cancer-treatment-072219992.html

AstraZeneca abandons lung cancer treatment trial in fresh setback for drugs giant

3+ week, 6+ day ago   (349+ words) Pharmaceutical giant AstraZeneca has suffered a fresh setback after pulling the plug on a late-stage lung cancer drug trial. The FTSE 100 group revealed that its Volrustomig treatment, when combined with chemotherapy, was unlikely to increase survival rates for lung cancer…...